Patrick Ott
MD, PhD
Associate Professor of Medicine
👥Biography 个人简介
Patrick Ott led the landmark NeoVax personalized neoantigen vaccine clinical trials at Dana-Farber Cancer Institute, demonstrating safety and immunogenicity in melanoma patients. His Phase 1 trial results showed that neoantigen vaccines combined with anti-PD-1 therapy produced durable responses. He has continued to advance neoantigen vaccine development into glioblastoma and other tumor types. His clinical research has established the proof-of-concept for personalized cancer vaccines in humans.
🧪Research Fields 研究领域
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-03-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Drew M. Pardoll
Johns Hopkins University
Padmanee Sharma
MD Anderson Cancer Center
Naiyer A. Rizvi
Columbia University Irving Medical Center
关注 Patrick Ott 的研究动态
Follow Patrick Ott's research updates
留下邮箱，当我们发布与 Patrick Ott（Dana-Farber Cancer Institute）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment